LEADER 01568nam  2200421 n 450 
001 9910714992503321
005 20221031225052.0
035   $a(CKB)3710000000926514
035   $a(NjHacI)993710000000926514
035   $a(OCoLC)969457150
035   $a(EXLCZ)993710000000926514
100   $a20221031d2016      uy             0
101 0 $aeng
135   $aur|||||||||||
181   $ctxt$2rdacontent
182   $cc$2rdamedia
183   $acr$2rdacarrier
200 10$aOmega-3 fatty acids and cardiovascular disease $ean updated systematic review /$fEthan M Balk [and twelve others]
210  1$aRockville (MD) :$cAgency for Healthcare Research and Quality (US),$d[2016]
210  4$dİ2016
215   $a1 online resource (1252 pages) $cillustrations
225 1 $aEvidence Reports/Technology Assessments ;$vNumber 223
300   $a"August 2016."
320   $aIncludes bibliographical references.
410  0$aEvidence report/technology assessment ;$vNumber 223.
517   $aOmega-3 fatty acids and cardiovascular disease
606   $aCardiovascular system$xDiseases$xNutritional aspects
615  0$aCardiovascular system$xDiseases$xNutritional aspects.
676   $a616.10654
700   $aBalk$b Ethan$01351609
712 02$aUnited States.$bAgency for Healthcare Research and Quality,
712 02$aBrown University Center for Evidence-Based Medicine.
801  0$bNjHacI
801  1$bNjHacl
906   $aBOOK
912   $a9910714992503321
996   $aOmega-3 fatty acids and cardiovascular disease$93309468
997   $aUNINA